New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
March 10, 2014
05:42 EDTEWEdwards Lifesciences upgraded to Outperform from Market Perform at Wells Fargo
Wells Fargo upgraded Edwards Lifesciences citing a number of positive developments since it downgraded the stock in December 2013, including strong Q4 Sapien results outside the U.S. and the company's successful first-inman transcatheter mitral valve implants. Wells raised its price target range for shares to $82-$83 from $67-$69.
News For EW From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
There are no results for EW

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use